A. Mendizabal

发表

International patterns of childhood chronic myeloid leukemia: Comparisons between the United States and resource‐restricted nations

P. Levine, G. Reaman, K. Sadak, 2014, Pediatric blood & cancer.

J. Kurtzberg, V. Prasad, P. Szabolcs, 2008, Blood.

Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation.

J. Dipersio, J. Kurtzberg, M. Boeckh, 2010, Blood.

Higher risk of cytomegalovirus and aspergillus infections in recipients of T cell-depleted unrelated bone marrow: analysis of infectious complications in patients treated with T cell depletion versus immunosuppressive therapy to prevent graft-versus-host disease.

G. Papanicolaou, J. Wagner, S. Yanovich, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial

Daniel Berman, Eduardo Marbán, Albert C Lardo, 2012, The Lancet.

Results of a Randomized, Double-Blind Trial of Fluconazole (FLU) vs. Voriconazole (VORI) for the Prevention of Invasive Fungal Infections (IFI) in 600 Allogeneic Blood and Marrow Transplant (BMT) Patients.

J. Dipersio, J. Kurtzberg, M. Boeckh, 2007 .

A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.

J. Kurtzberg, D. Niedzwiecki, K. Komanduri, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Total colony-forming units are a strong, independent predictor of neutrophil and platelet engraftment after unrelated umbilical cord blood transplantation: a single-center analysis of 435 cord blood transplants.

J. Kurtzberg, A. Balber, T. Gentry, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction).

R. Bonow, E. Marbán, A. Lardo, 2014, Journal of the American College of Cardiology.

Autologous Mesenchymal Stem Cells Produce Concordant Improvements in Regional Function, Tissue Perfusion, and Fibrotic Burden When Administered to Patients Undergoing Coronary Artery Bypass Grafting: The Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Sur

Katherine C. Wu, P. Pattany, A. Lardo, 2014, Circulation research.

Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation.

S. Pai, H. Heslop, C. Rooney, 2013, Blood.

Myeloablative versus Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation in Acute Myelogenous Leukemia and Myelodysplastic Syndromes-Long-Term Follow-Up of the BMT CTN 0901 Clinical Trial.

E. Leifer, N. Geller, D. Porter, 2021, Transplantation and cellular therapy.

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.

E. Leifer, N. Geller, H. Deeg, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Late Effects after Umbilical Cord Blood Transplantation in Very Young Children after Busulfan-Based, Myeloablative Conditioning.

J. Kurtzberg, V. Prasad, J. Sanders, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Influence of T-cell depletion on chronic graft-versus-host disease: results of a multicenter randomized trial in unrelated marrow donor transplantation.

D. Weisdorf, R. Gingrich, S. Pavletic, 2005, Blood.

Characteristics of CliniMACS® System CD34-enriched T cell-depleted grafts in a multicenter trial for acute myeloid leukemia-Blood and Marrow Transplant Clinical Trials Network (BMT CTN) protocol 0303.

P. Hari, M. Pasquini, R. Soiffer, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.

Joshua M Hare, Phillip Ruiz, Peter A. Altman, 2012, JAMA.

Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial

A. Heldman, A. Oliva, A. Landin, 2017, The journals of gerontology. Series A, Biological sciences and medical sciences.

Autologous Hematopoietic Stem Cell Transplantation (AHCT) in Patients with Chemotherapy-Sensitive, Relapsed/Refractory (CSRR) Human Immunodeficiency Virus (HIV)-Associated Lymphoma (HAL): Results from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0803)/AIDS Malignancy Consortium (

U. Popat, S. Devine, R. Ambinder, 2014 .

Recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: consensus opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN).

F. Appelbaum, M. Pasquini, M. Horowitz, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Recommendations for Donor HLA Assessment and Matching for Allogeneic Stem Cell Transplantation : Consensus Opinion of the Blood and Marrow Transplant Clinical Trials Network ( BMT CTN )

F. Appelbaum, M. Pasquini, M. Horowitz, 2014 .

Intramyocardial Stem Cell Injection in Patients With Ischemic Cardiomyopathy: Functional Recovery and Reverse Remodeling

Peter A. Altman, P. Pattany, A. Heldman, 2011, Circulation research.

Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.

Darcy L. DiFede, Peter A. Altman, R. Hendel, 2014, JAMA.

Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy (The TRIDENT Study)

Robert C. Hendel, Darcy L. DiFede, Joshua M. Hare, 2017, Circulation research.

Myeloablative transplantation using either cord blood or bone marrow leads to immune recovery, high long-term donor chimerism and excellent survival in chronic granulomatous disease.

J. Kurtzberg, H. Malech, V. Prasad, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial.

A. Krishnan, G. Lozanski, M. Horowitz, 2016, Blood.

Posttransplant autoimmune hemolytic anemia and other autoimmune cytopenias are increased in very young infants undergoing unrelated donor umbilical cord blood transplantation.

J. Kurtzberg, G. Sempowski, V. Prasad, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A scheme for defining cause of death and its application in the T cell depletion trial.

J. Wagner, E. Copelan, D. Hurd, 2007, Biology of Blood and Marrow Transplantation.

Post Transplant Autoimmune Hemolytic Anemia and Other Cytopenias Are Increased in Very Young Babies after Unrelated Donor Umbilical Cord Blood Transplantation.

J. Kurtzberg, V. Prasad, P. Szabolcs, 2007 .

Optimizing donor selection for public cord blood banking: influence of maternal, infant, and collection characteristics on cord blood unit quality

Jessica M Sun, J. Kurtzberg, B. Betz-Stablein, 2013, Transfusion.

Umbilical Cord Blood Transplantation in Children with Acute Leukemia: Impact of Conditioning on Transplantation Outcomes.

J. Wagner, J. Kurtzberg, M. Horowitz, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Blood and Marrow Transplant Clinical Trials Network Report on the Development of Novel Endpoints and Selection of Promising Approaches for Graft-versus-Host Disease Prevention Trials.

M. Perales, F. Appelbaum, D. Porter, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The Cord Blood Apgar: a novel scoring system to optimize selection of banked cord blood grafts for transplantation (CME)

J. Kurtzberg, A. Balber, T. Gentry, 2012, Transfusion.

Umbilical Cord Blood Transplantation in Children with Acute Leukemia: Impact of Conditioning on Transplant Outcomes Blood Marrow

J. Wagner, J. Kurtzberg, D. Wall, 2017 .

Umbilical Cord Blood Transplantation in Children with Acute Leukemia : Impact of Conditioning on Transplant Outcomes Short Title : Cord Blood Transplant for Acute Leukemia

J. Wagner, J. Kurtzberg, M. Horowitz, 2017 .

Rationale and Design of the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis in Dilated Cardiomyopathy (The POSEIDON-DCM Study)

A. Heldman, J. Hare, S. Gomes, 2014, Journal of Cardiovascular Translational Research.

Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-versus-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell transplantation.

F. Appelbaum, M. Pasquini, M. Horowitz, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

J. Kurtzberg, V. Prasad, P. Szabolcs, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effect of aging on human mesenchymal stem cell therapy in ischemic cardiomyopathy patients.

E. Ghersin, J. Hare, J. Fishman, 2014, Journal of the American College of Cardiology.

Biologic Assignment Trial of Reduced-Intensity Hematopoietic Cell Transplantation Based on Donor Availability in Patients 50-75 Years of Age With Advanced Myelodysplastic Syndrome

E. Leifer, P. Westervelt, F. Appelbaum, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Multi-Center Biologic Assignment Trial Comparing Reduced Intensity Allogeneic Hematopoietic Cell Transplantation to Hypomethylating Therapy or Best Supportive Care in Patients Aged 50-75 with Advanced Myelodysplastic Syndrome: Blood and Marrow Transplant Clinical Trials Network Study 1102

E. Leifer, P. Westervelt, F. Appelbaum, 2020, Transplantation and Cellular Therapy.

Results of a Phase III Randomized, Multi-Center Study of Allogeneic Stem Cell Transplantation after High Versus Reduced Intensity Conditioning in Patients with Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML): Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0901

E. Leifer, N. Geller, H. Deeg, 2015 .

A phase II/III randomized, multicenter trial of prednisone/sirolimus versus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-versus-host disease: BMT CTN 0801

M. Horowitz, J. Bolaños-Meade, Stephanie J. Lee, 2018, Haematologica.

Phase II trial of parathyroid hormone after double umbilical cord blood transplantation.

E. Shpall, J. Wingard, K. Ballen, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Phase II Trial of Parathyroid Hormone following Double Umbilical Cord Blood Transplantation

E. Shpall, J. Wingard, K. Ballen, 2012 .

Neurodevelopmental outcomes of umbilical cord blood transplantation in metachromatic leukodystrophy.

M. Poe, J. Provenzale, J. Kurtzberg, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor–Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies

N. Geller, M. Perales, H. Heslop, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Calcineurin Inhibitor-Free Graft-Versus-Host Disease (GVHD) Prophylaxis in Hematopoietic Cell Transplantation (HCT) with Myeloablative Conditioning Regimens (MAC) and HLA-Matched Donors: Results of the BMT CTN 1301 Progress II Trial

N. Geller, M. Perales, H. Heslop, 2021 .

Phase 3 clinical trial of steroids/mycophenolate mofetil vs steroids/placebo as therapy for acute GVHD: BMT CTN 0802.

P. Westervelt, M. Pasquini, M. Horowitz, 2014, Blood.

Does Transendocardial Injection of Mesenchymal Stem Cells Improve Myocardial Function Locally or Globally?Novelty and Significance

Peter A. Altman, Katarina H. Nelson, A. Lardo, 2014 .

Immune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 Trial

C. Hofmeister, A. Krishnan, W. Wachsman, 2021, Frontiers in Immunology.

Allogeneic hematopoietic cell transplant for HIV patients with hematologic malignancies: the BMT CTN-0903/AMC-080 trial.

J. Mellors, D. Porter, M. Horowitz, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Juan Wu, M. Eapen, E. Fuchs, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical Trial

G. Rosen, J. Minkiewicz, M. Glassberg, 2017, Chest.

Multicenter biologic assignment trial comparing reduced-intensity allogeneic hematopoietic cell transplant to hypomethylating therapy or best supportive care in patients aged 50 to 75 with intermediate-2 and high-risk myelodysplastic syndrome: Blood and Marrow Transplant Clinical Trials Network #110

E. Leifer, F. Appelbaum, M. Horowitz, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and effi

Peter A. Altman, A. Heldman, D. Rouy, 2011, American heart journal.

Most Closely HLA-Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) to Treat Persistent Reactivation or Infection With Adenovirus, CMV and EBV After Hemopoietic Stem Cell Transplantation (HSCT)

S. Pai, H. Heslop, C. Rooney, 2010 .

Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial.

R. Hendel, P. Pattany, Mauricio G. Cohen, 2017, Journal of the American College of Cardiology.

Impact of Autologous Hematopoietic Cell Transplant (HCT) Followed By Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance in Increasing Multiple Myeloma (MM) Immunity (BMT CTN 1401)

N. Geller, N. Munshi, M. Pasquini, 2021, Blood.

Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty

A. Heldman, A. Oliva, A. Landin, 2017, The journals of gerontology. Series A, Biological sciences and medical sciences.

Geographic and income variations in age at diagnosis and incidence of chronic myeloid leukemia

P. Levine, N. Younes, A. Mendizabal, 2015, International Journal of Hematology.

Regional variations in age at diagnosis and overall survival among patients with chronic myeloid leukemia from low and middle income countries.

P. Levine, Pat Garcia-Gonzalez, A. Mendizabal, 2013, Cancer epidemiology.

Allogeneic hematopoietic cell transplant (alloHCT) for hematologic malignancies in human immunodeficiency virus infected (HIV) patients (pts): Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0903)/AIDS Malignancy Consortium (AMC-080) trial.

J. Mellors, M. Horowitz, U. Popat, 2017 .

Does Transendocardial Injection of Mesenchymal Stem Cells Improve Myocardial Function Locally or Globally?: An Analysis From the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) Randomized Trial

Peter A. Altman, Katarina H. Nelson, A. Lardo, 2014, Circulation research.

Preliminary Results of a Pilot Trial of Unrelated Umbilical Cord Blood Transplantation (UCBT) Augmented with Cytokine-Primed Aldehyde Dehydrogenase-Bright (ALDHbr) Cells.

J. Kurtzberg, A. Balber, T. Gentry, 2006 .

Effects of Transendocardial Stem Cell Injection on Ventricular Proarrhythmia in Patients with Ischemic Cardiomyopathy: Results from the POSEIDON and TAC‐HFT Trials

J. Goldberger, R. Myerburg, A. Heldman, 2017, Stem cells translational medicine.

Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial.

R. Hendel, P. Pattany, Mauricio G. Cohen, 2017, Journal of the American College of Cardiology.

Autologous Mesenchymal Stem Cells Produce Concordant Improvements in Regional Function, Tissue Perfusion and Fibrotic Burden when Administered to Patients Undergoing Coronary Artery Bypass Grafting – The PROMETHEUS Trial

P. Pattany, A. Lardo, A. Heldman, 2014 .

Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3

J. Wingard, A. Mishra, M. Levis, 2024, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

105: Augmentation of Standard Umbilical Cord Blood Transplantation with ALDHbr Cells: Results of a Phase I Study in Pediatric Patients

J. Kurtzberg, A. Balber, D. Hickerson, 2008 .